Skip to main content
GlobeStar Therapeutics Corporation (GSTC)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Mar 2, 2026

GlobeStar Therapeutics Income Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
 TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
 Jun '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 2018 - 2016
Revenue
----00
Upgrade
Revenue Growth (YoY)
-----81.88%-52.25%
Upgrade
Cost of Revenue
---00.040
Upgrade
Gross Profit
----0-0.040
Upgrade
Selling, General & Admin
0.81.861.279.090.270.32
Upgrade
Operating Expenses
0.81.861.279.090.270.32
Upgrade
Operating Income
-0.8-1.86-1.27-9.09-0.3-0.32
Upgrade
Interest Expense
-0.08-0.09-0.07-0.29-0.24-0.36
Upgrade
EBT Excluding Unusual Items
-0.89-1.96-1.34-9.38-0.54-0.68
Upgrade
Gain (Loss) on Sale of Investments
------0.01
Upgrade
Other Unusual Items
-0.01-0.15-0.42-0.01
Upgrade
Pretax Income
-0.89-1.95-1.49-9.8-0.54-0.68
Upgrade
Earnings From Continuing Operations
-0.89-1.95-1.49-9.8-0.54-0.68
Upgrade
Net Income
-0.89-1.95-1.49-9.8-0.54-0.68
Upgrade
Preferred Dividends & Other Adjustments
0.03----1.6
Upgrade
Net Income to Common
-0.92-1.95-1.49-9.8-0.54-2.28
Upgrade
Shares Outstanding (Basic)
1,069827629482298105
Upgrade
Shares Outstanding (Diluted)
1,069827629482298105
Upgrade
Shares Change (YoY)
39.10%31.63%30.38%61.73%184.50%85.40%
Upgrade
EPS (Basic)
-0.00-0.00-0.00-0.02-0.00-0.02
Upgrade
EPS (Diluted)
-0.00-0.00-0.00-0.02-0.00-0.02
Upgrade
Free Cash Flow
-0.15-0.21-0.33-0.75-0.24-0.26
Upgrade
Free Cash Flow Per Share
---0.00-0.00-0.00-0.00
Upgrade
Gross Margin
-----63.77%
Upgrade
Operating Margin
-----394377.92%-74322.35%
Upgrade
Profit Margin
-----703546.75%-535311.06%
Upgrade
Free Cash Flow Margin
-----313658.44%-61208.94%
Upgrade
EBITDA
---1.26-9.09-0.3-0.32
Upgrade
D&A For EBITDA
--0000
Upgrade
EBIT
-0.8-1.86-1.27-9.09-0.3-0.32
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.